Ads
related to: myelocytic leukemiahealthline.com has been visited by 10K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1]
Myeloid leukemia is a type of leukemia affecting myeloid tissue. Types include: Acute myeloid leukemia : A cancer of the myeloid line of blood cells , characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production .
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells.It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood.
Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells. [3] In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes .
Chronic myelomonocytic leukemia (CMML) is a type of leukemia, which are cancers of the blood-forming cells of the bone marrow. In adults, blood cells are formed in the bone marrow, by a process that is known as haematopoiesis .
Acute myeloid leukemia is a very heterogeneous disease, composed of a variety of translocations and mutations. However, one tenth of all acute myeloid leukemia cases diagnosed have the AML1-ETO fusion oncoprotein due to the t(8;21) translocation. AML1 or RUNX1 is a DNA-binding transcription factor located at the 21q22.
Ads
related to: myelocytic leukemiahealthline.com has been visited by 10K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month